Advances in cell death - related signaling pathways in acute-on-chronic liver failure

Acute-on-chronic liver failure (ACLF) has been a hot spot in the field of liver disease research in recent years, with high morbidity, rapid course change and high mortality. Currently, there is the absence of specific treatment in clinical practice. Liver transplantation has the best therapeutic ef...

Full description

Saved in:
Bibliographic Details
Published in:Clinics and research in hepatology and gastroenterology Vol. 46; no. 2; p. 101783
Main Authors: Huang, Liqiao, Liu, Jie, Bie, Caiqun, Liu, Helu, Ji, Yichun, Chen, Dongfeng, Zhu, Meiling, Kuang, Weihong
Format: Journal Article
Language:English
Published: France Elsevier Masson SAS 01-02-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acute-on-chronic liver failure (ACLF) has been a hot spot in the field of liver disease research in recent years, with high morbidity, rapid course change and high mortality. Currently, there is the absence of specific treatment in clinical practice. Liver transplantation has the best therapeutic effect, but it is prone to have internal environment disorder and liver cell death after transplantation, which leads to the failure of transplantation.In recent years, with the development of molecular biology, scholars have explored the treatment of ACLF at the molecular level, and more and more molecular signaling pathways related to the treatment of ACLF have been discovered. Modulating the relevant signaling pathways to reduce the mortality of liver cells after transplantation may effectively improve the success rate of transplantation. In this review, we introduce some signaling pathways related to cell death and their research progress in acute-on-chronic liver failure.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2210-7401
2210-741X
DOI:10.1016/j.clinre.2021.101783